ISRCTN14341750已完成未知
ILS: Non-Invasive Lymph node Staging
und University0 个研究点目标入组 23,400 人开始时间: 2018年11月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 23,400
研究概览
简要总结
2017 Results article in https://www.ncbi.nlm.nih.gov/pubmed/28718896 Nomogram initial results 2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31226956 Artificial neural network modeling initial results (added 24/06/2019) 2021 Other publications in https://doi.org/10.1093/bjsopen/zrab027 Nomogram validation (added 31/08/2021) 2024 Results article in https://pubmed.ncbi.nlm.nih.gov/38229058/ Retrospective validation study (added 22/01/2024)
研究设计
- 研究类型
- Observational
入排标准
- 性别
- Female
入选标准
- •Current inclusion criteria as of 31/08/2021:
- •1. Invasive breast cancer
- •2. Clinically and ultrasound node-negative disease
- •3. Scheduled for primary surgery
- •Previous inclusion criteria:
- •1. Invasive breast cancer
- •2. Clinically node-negative disease
- •3. Scheduled for primary surgery
排除标准
- •2. Previous ipsilateral breast or axillary surgery
- •3. Previous neoadjuvant therapy
- •4. Palpable axillary lymphadenopathy
- •5. No axillary staging
研究者
相似试验
已完成
1 期
NIR-Guided Sentinel Lymph-Node Mapping for Esophageal CancerEsophageal CancerNCT01808417Dana-Farber Cancer Institute10
进行中（未招募）
不适用
Biopsy ME study - Node biopsy for patients with early stage Merkel Cell Carcinoma,ACTRN12618000528257South Western Sydney Local Health District29
终止
不适用
Sentinel Lymph Node Procedure in Ipsilateral Invasive Breast Cancer RelapseIpsilateral RecurrenceSentinel Lymph Node BiopsyInvasive Breast CancerNCT03630653Institut Cancerologie de l'Ouest50
已完成
不适用
5-ALA in bowel cancer surgeryTopic: National Cancer Research NetworkSubtopic: Colorectal CancerDisease: ColonMalignant neoplasm of colonCancerISRCTN79949827niversity of Leeds (UK)52
Enrolling By Invitation
1 期
Sentinel lymph node mapping and ultrastaging in patients with early stage cervical cancerEarly stage cervical cancer (stage IA2-IIA)Early stage cervical cancer, sentinel lymph node, ultastagingTCTR20210314002/A23